These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1153154)

  • 1. Complete vaginal occlusion in postmenopausal women.
    Parmley TH; Woodruff JD
    Obstet Gynecol; 1975 Aug; 46(2):235-8. PubMed ID: 1153154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause.
    Repse-Fokter A; Takac I; Fokter SK
    Gynecol Endocrinol; 2008 Jul; 24(7):399-404. PubMed ID: 18645712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of patients with vaginal rupture and evisceration.
    Croak AJ; Gebhart JB; Klingele CJ; Schroeder G; Lee RA; Podratz KC
    Obstet Gynecol; 2004 Mar; 103(3):572-6. PubMed ID: 14990423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position of the Spanish Menopause Society regarding vaginal health care in postmenopausal women.
    Sánchez-Borrego R; Manubens M; Navarro MC; Cancelo MJ; Beltrán E; Duran M; Orte T; Baquedano L; Palacios S; Mendoza N;
    Maturitas; 2014 Jun; 78(2):146-50. PubMed ID: 24720907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical and patient attitude towards vaginal atrophy: the AGATA study.
    Palma F; Della Vecchia E; Cagnacci A;
    Climacteric; 2016 Dec; 19(6):553-557. PubMed ID: 27736240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goblet-like cells in atrophic vaginal smears and their histologic correlation. Possible confusion with endocervical cells.
    Koike N; Higuchi T; Sakai Y
    Acta Cytol; 1990; 34(6):785-8. PubMed ID: 1701599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
    Al-Baghdadi O; Ewies AA
    Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe atrophic vaginitis causing vaginal synechiae and hematocolpos at menopause.
    Segal S; Harvie HS; Siegelman E; Arya LA
    Menopause; 2011 Mar; 18(3):333-5. PubMed ID: 21301374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial.
    Costantino D; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2008; 12(6):411-6. PubMed ID: 19146203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulvovaginal complaints.
    Mehta A; Bachmann G
    Clin Obstet Gynecol; 2008 Sep; 51(3):549-55. PubMed ID: 18677149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
    Bateson DJ; Weisberg E
    Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolapse of appendices epiploicae due to vaginal vault [corrected] rupture].
    Pelikan HM; Engelen MJ
    Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2281-3. PubMed ID: 17987898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An acquired sensation of wide/smooth vagina: a new classification.
    Ostrzenski A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):97-100. PubMed ID: 21620554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI of vaginal conditions.
    López C; Balogun M; Ganesan R; Olliff JF
    Clin Radiol; 2005 Jun; 60(6):648-62. PubMed ID: 16038691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal evisceration: presentation and management in postmenopausal women.
    Kowalski LD; Seski JC; Timmins PF; Kanbour AI; Kunschner AJ; Kanbour-Shakir A
    J Am Coll Surg; 1996 Sep; 183(3):225-9. PubMed ID: 8784315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
    Cotreau MM; Chennathukuzhi VM; Harris HA; Han L; Dorner AJ; Apseloff G; Varadarajan U; Hatstat E; Zakaria M; Strahs AL; Crabtree JS; Winneker RC; Jelinsky SA
    Maturitas; 2007 Dec; 58(4):366-76. PubMed ID: 17997058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.